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1.  LIST OF ABREVIATIONS
TJR Total joint replacement
PBMC Peripheral Blood Mononuclear Cell 
BMC Bone marrow cells
RANKL Receptor activator of nuclear factor (NF)-κB ligand
M-CSF Macrophage colony stimulating factor
TNF alpha Tumor necrosis factor alpha
IL-6                                        Interleukin-6 
VEGF Vascular endothelial growth factor
TRAP Tartrate resistant acid phosphatase
ELISA Enzyme-linked immunosorbent assay
BSA Bovine serum albumin
FCS Fetal calf serum
PCR Polymerase chain reaction
α-MEM α -minimum essential medium
RT Room temperature
RNA Ribonucleic acid
cDNA Complementary deoxyribonucleic acid
2. INTRODUCTION
Synovial  joints  in  the  human  body  (hip,  knee,  shoulder  joints…)  are  structures  capable  of 
functioning  under  critical  conditions.  Their  behavior  and  endurance  is  due  to  the  optimized 
combination of cartilage (a dense connective tissue covering the bones involved in the joint), and 
synovial fluid (nutrient fluid secreted within the joint area).
With  the  increase  of  life  expectancy,  the  prevalence  of  osteoarthritis  –  a  degenerative  joint 
diseases – is also increasing. The resulting pain and joint stiffness is posing a major burden on 
affected individuals as well as on society. In fact, according to Bjelle [1], degenerative joint disease 
it is  the second most frequent chronic condition in Europe.
Total joint arthroplasty  – the replacement of diseased joint surfaces by metal, plastic, or ceramic 
artificial materials - is recognized as a major achievement in treating this immobilizing disease. 
The longevity of arthroplasties has become an important issue in orthopaedic surgery. The lifespan 
of implants is mainly limited by a process called aseptic loosening. During this process the contact 
between bone and the implant  surface is  lost  and the prosthesis  becomes loose.  Although the 
trigger  of  aseptic  loosening  is  still  under  investigation  it  is  known  that  wear  particles  from the 
articulating surface are playing a role. An additional aspect in the development of aseptic loosening 
might  be  host  responses  to  metals.  Implant  alloys  in  contact  with  biological  systems  undergo 
corrosion, leading to the release of metal ions into the periprosthetic tissues and the circulation. 
These increased levels of metal ions (Ni2+, Co2+, Ti3+, and of other metal ions), which may remain 
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free  or  become  bound  to  proteins  [2,3],  may  lead  to  a  chronic  inflammatory  response  as  a 
consequence, which, may induce resorption of the peri-implant bone [4,5].
2.1 Bone Biology
Bones are  part  of  the endoskeleton of  all  higher  vertebrates.  Bone is  a  composite  and complex 
dynamic system that is made up of various tissue types such as bone marrow, periosteum, nerves, 
blood vessels and cartilage, but mostly of mineralized osseous tissue. This anisothopic tissue, formed 
mainly  by  calcium hydroxylapatite,  is  relatively  hard  and  lightweight.  And  although  it  has  a  high 
compressive strength, it  possesses only poor tensile strength. It is essentially brittle but still  has a 
significant degree of elasticity, mainly due to the presence of collagen I.
These attributes aid multiple functions of bone that include: protecting internal organs; providing a 
scaffold to support the body; serving as levers for muscles; buffering blood pH by absorption and 
release of  alkaline salts;  detoxifying  by storage and gradual  release of  heavy  metals;  serving  as 
mineral  reserves,  mostly  notable  for  calcium  and  phosphate;  and  producing  blood  cells  through 
hematopoiesis in the red bone marrow.
Bones are either woven or lamellar (layered). Although woven bone is weak because it possesses 
only a small number of randomly oriented collagen fibers, it forms quickly and does not require a pre-
existing structure for growth. Lamellar bone is stronger, as it consists of numerous stacked layers that 
are filled with collagen fibers running in opposite directions in alternating layers, but it forms slowly.
Bone is subject to the complex process of bone remodeling. A German anatomist Julius Wolff in the 
19th century postulate the Wolff law: “Bone adapts to the loads it is placed under”. The cycle of bone 
resorption by osteoclasts and bone formation by osteoblasts is life-long. It serves three main purposes 
– adaption to changing forces in specific regions, damage repair, and calcium homeostasis.
The complex tissue of bone is made up of many different cell types. On the surface of the bone there 
are pluripotent, fibroblast-like, mesenchymal cells, called osteoprogenitor cells. These cells give rise to 
preosteoblasts. These preosteoblasts can develop towards osteoblasts and further towards osteocytes 
and lining cells.
2.1.1 Osteocytes
Osteocytes originate from migrating osteoblasts that have become surrounded by bone matrix, which 
they  themselves  produced.  Their  occupied  space  is  known  as  lacunae.  Osteocytes  contribute  in 
varying degrees to a  number of  functions that  include:  bone formation,  calcium homeostasis,  cell 
communication,  and  matrix  maintenance.  It  is  also  possible  that  they  regulate  the  bone’s  stress 
response  through  functioning  as  mechanosensory  receptors.  Bone  lining  cells  cover  the  entire 
available surface of the bone. They are flat and are essentially inactive osteoblasts that serve as a 
barrier  against  certain  ions.  They  are  also  considered  as  putative  osteoblast  progenitor  cells, 
respectively resting osteoblasts.
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2.1.2 Osteoblasts
Osteoblasts  are  mononucleated  bone-forming  cells  that  emerge  from preosteoblasts.  Osteoblasts 
produce osteoid, a protein mixture consisting mainly of type I collagen that later mineralizes to become 
bone.  Osteoblasts  also  manufacture  many  matrix  proteins,  such  as:  osteocalcin;  sialoprotein; 
osteopontin;  receptors  for  growth  factors  and  hormones;  different  types  of  proteoglycanes;  and 
hormones such as prostaglandins that act on the bone itself. Osteoblasts also stably produce alkaline 
phosphatase, a key enzyme in bone mineralization.
2.1.3 Osteoclasts
Osteoclasts act antagonistically to osteoblasts. They are located on the bone surface in what is called 
Howship’s lacunae, or resorption pits, and are responsible for bone resorption. 
The osteoclast was first  named and functionally characterized by Kölliker in the late 19th century. 
However, its origin and its physiology remained obscure for long, until parabiosis (fusion of embryos 
experiments provided the first clear evidence that osteoclasts originate from circulating cells [5]. Later 
it was shown that a mixed primary cell culture of macrophages and monocytes can be converted into 
osteoclasts [6]. Because of the observation that cell-cell interactions between mononuclear phagocyte 
progenitors  and  bone  stromal  cells  seemed  to  be  essential  for  in  vitro  osteoclastogenesis,  a 
membrane associated osteoclast differentiation factor (ODF) on bone stromal cells was postulated. 
This hypothesis was controversially discussed for several years until 1998 when Receptor activator of 
nuclear factor (NF)-κB ligand (RANKL) was shown to be the essential osteoclastogenic factor in Co-
culture [7]. As predicted, RANKL is almost entirely expressed as a cell membrane-associated factor of 
osteoblasts. The more active soluble form of RANKL (sRANKL) derives from the membrane bound 
form  by  proteolytic  cleavage  or  alternative  splicing  [8].  Cleavage  requires  disintegrin  and 
metalloprotease  domain  (ADAM)  family  members  and  matrix  metalloproteases  (MMP)  [9].  For 
differentiation, a specialized bone marrow milieu is required since RANKL expressed in other locations 
does not cause osteoclast formation.
In vitro osteoclast cell culture systems were established in the following years by culturing isolated 
osteoclast precursor cells in the presence of both RANKL and macrophage colony stimulating factor 
(M-CSF; CSF-1). M-CSF is required for proliferation of differentiating osteoclasts and their precursors. 
M-CSF  is  the  growth  factor  for  cells  of  the  monocyte-macrophage  lineage  and  supports  the 
proliferation, survival and differentiation of cells from monocyte to macrophages.
Continuous RANKL stimulation of mature osteoclasts leads to enhanced resorptive activity and, in 
combination with IL-1 (Interleukin 1), it prolongs osteoclast survival [10].
It is possible that there are pathways acting parallel to CSF-1 and RANKL that can supply additional 
stimulation for efficient osteoclast formation. Immune tyrosine-based activation motif (ITAM) adapters 
and  Syk  nonreceptor  tyrosine  kinases  are  potential  candidates  [11].  Another  candidate  is  tumor 
necrosis factor-α (TNFα), which is reported to permit formation of resorbing osteoclasts in the absence 
of RANKL. There is controversy about these findings, but most studies agree that TNFα is at least a 
co-stimulus for differentiation [12].
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Once differentiated,  osteoclast  survival  is  regulated by numerous hormones,  cytokines,  and other 
factors. Some of the known factors are: interleukins 1, 6 and 11; transforming growth factor-α (TGFα); 
TNFα;  and  different  systemic  hormones  –  parathyroid  hormone,  calcitonin,  calcitriol,  and 
prostaglandins [13].
An  important  antagonist  in  osteoclastogenesis  is  osteoprotegerin  (OPG).  Molecular  binding 
experiments showed that OPG associates with RANKL and functions as a decoy receptor [14].
OPG is secreted by osteoblasts as a response to estrogens or bone morphogenetic proteins (BMP), 
which  are  members  of  the transforming  growth  factor-β  (TGF-β)-  superfamily  which  induce  bone 
formation. The antagonistic interplay of RANKL and OPG has direct relevance to human disease.
Osteoclast  differentiation  is  characterized  by  different  features:  polynucleation  due  to  cell  fusion; 
formation of ruffled borders for proton, enzyme and acid secretion; associated synthesis of vacuolar 
proton pumps and different enzymes; and formation of a sealing zone to prevent enzyme and acid 
leakage.
Because not only polynucleated but also mononuclear osteoclasts express TRAP (tartrate resistant 
acid phosphatase), calcitonin receptor (CTR), and matrix metalloproteinase (MMP), and resorb bone, 
polynucleation is the most characteristic feature of mature osteoclasts. 
Cell fusion is not a specific phenomenon for osteoclasts, as it can be observed in other tissues, such 
as placentas or myotubules. However, osteoclasts are the largest of these cells. The mechanism of 
cell  fusion is not  studied well  yet,  but  it  seems to  have similarities  to viral  fusion.  Multinucleated 
osteoclasts are highly polarized cells. As mentioned, they form new cytoskeletal elements such as 
ruffled borders and sealing zones when fused. These structures are located on the basal side and 
bone debris resorbed from this basal area is transferred to the apical side via transcytosis. Different 
lytic  enzymes  such  as  TRAP  and  pro-Cathepsin  K  (pro-CATK)  are  secreted  from  the  highly 
specialized  membrane into  the resorption pit  (Howship’s  lacunae).  By this  process the osteoclast 
erodes the underlying bone. Degradation products (collagen fragments and solubilized phosphate and 
calcium) are resorbed by the osteoclast, processed and then rereleased to metabolic circulation.
Figure 2: Overview of osteoclastogenesis
(SUDA et al., 2003).
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2.2 Joint arthroplasty
2.2.1 Materials Used in Orthopedic Implants 
The most common materials used in orthopedics implants are metals and polyethylene. These two 
material types are combined in most joint implants, that is, one component is made from metal, and 
one from polyethylene. When properly designed and implanted, the two components can rub together 
smoothly while minimizing wear. 
Most metal implants are alloys from a mixture of two or more metals. By combining metals, a new 
material can be created that has a good balance of the desired characteristics. The most common 
metal alloys used are stainless steels, cobalt-chromium alloys, and titanium alloys. 
Stainless Steel 
Stainless steel is a very strong alloy, and is most often used in implants that are intended to help 
repair fractures, such as bone plates, bone screws, pins, and rods. Stainless steel is made mostly of 
iron, with other metals such as chromium or molybdenum added to make it more resistant to 
corrosion, and Nickel to stabilize the austenitic phase. There are many different types of stainless 
steel. The stainless steels used in orthopedics implants are designed to resist the normal chemicals 
found in the human body.  The most used is the AISI 316L, composition: C: 0.03%, Cr:17-20%, 
Ni:12-14%, Mo:2-4%.  Corrosion is the principal defect of this alloy.
Cobalt-chromium Alloys 
Cobalt-chromium alloys are also strong, hard, biocompatible, and corrosion resistant (high 
concentration of Cr, that form a passive layer of Cr2O3 on the surface of the implant). These alloys are 
used in a variety of joint replacement implants, as well as some fracture repair implants, that require a 
long service life. While cobalt-chromium alloys contain mostly cobalt and chromium, they also include 
other metals, such as molybdenum, to increase their strength. It has the higher Young Modulus, 
helping the oseointergration, but is more fragile.
Titanium Alloys 
Titanium alloys are considered to be biocompatible. They are the most flexible of all orthopaedic 
alloys. They are also lighter weight than most other orthopedic  alloys. Consisting mostly of titanium, 
they also contain varying degrees of other metals, such as aluminum and vanadium. Passivation is 
due to the spontaneous formation of TiO2 on the surface of the metal.
Titanium 
Pure titanium may also be used in some implants where high strength is not required. It is used, for 
example, to make fiber metal, which is a layer of metal fibers bonded to the surface of an implant to 
allow the bone to grow into the implant, or cement to flow into the implant, for a better grip. 
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Polyethylene 
Polyethylene (PE) is a type of plastic commonly used on the surface of one implant that is designed to 
articulate with another implant, as in a joint replacement. The most important issue of PE is the 
production of wear particles which accumulate over time within the per-implant tissue. 
Patients who are younger or more active may benefit from polyethylene with even more resistance to 
wear. This can be accomplished through a process called cross-linking, which creates stronger bonds 
between the molecular strands that make up the polyethylene. This cross-linking is induced by gamma 
irradiation. The appropriate amount of cross-linking depends on the type of implant. For example, the 
surface of a hip implant may require a different degree of cross-linking than the surface of a knee 
implant. 
Ceramics 
Ceramic materials are usually made by pressing and heating metal oxides (typically aluminum oxide 
and zirconium oxide) until they become very hard. These ceramic materials are strong, resistant to 
wear, and biocompatible. They are used mostly to make implant surfaces that rub together but do not 
require flexibility, as in the surfaces of a hip joint. A problem of this material is its brittleness. High 
impact forces into the joint might break the implant.
2.2.2 Implant properties
Strength
An orthopaedic implant should be designed to be as strong as possible. During daily activities, high 
levels of mechanical stress are placed on bones and joints. An implant must be able to withstand 
these stresses day to day without  breaking or permanently changing its shape. It  should also be 
designed to withstand the accumulated effect of repeating these stresses.
Flexibility (viscoelasticity)
They must also be flexible to avoid shielding of bones from stress shielding (the human body may tend 
to reduce or eliminate its own parts when they are not used). 
Bones can remain strong only if they are regularly placed under a reasonable stress. And if they are 
never  stressed,  the  body  will  actually  begin  to  lose  bone  tissue,  causing  the  remaining  bone  to 
become weak.
When stress is applied to an orthopaedic implant that is very stiff, the implant absorbs most of the 
stress. But when stress is applied to a more flexible implant, some of the stress passes through the 
implant so it can be shared with the surrounding bone. 
As is it showed in the figure 6, bone has an elastic modulus of approximately 40 GPa. The 3 metal 
alloys show  superior to bone elasticity, being the more similar the Ti6Al4V.
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Figure 5. Implants in the human body are forced to withstand and array of extrinsic factors that  
degrade them. 
Figure 6. Elastic Modulus of different materials [15]. 
Resistance to Wear 
In parts that touch each other or rub together, especially in the case of an artificial joint, friction is 
created and the parts may possibly wear over time. When an implant  wears,  tiny particles of  the 
material  are  removed from the surface and remain in  the tissues that  surround the implant.  The 
majority of the wear particles formed are less than 5 μm in diameter and are randomly shaped. These 
particles may cause a  reaction that  could  lead to  inflammation.  If  the  inflammation  is  severe,  or 
continues for too long, the implant may become loose.
Generally, the harder the material, the more resistant it is to wear. Also, the choice of the two materials 
that rub together in an implant is important in minimizing wear. Many combinations of materials are 
used today for implants, including metal on polyethylene, metal on metal, ceramic on ceramic, and 
ceramic on polyethylene. 
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Resistance to Corrosion 
Physiological medium is highly corrosive, electrochemical reactions (oxidation/reduction) can damage 
certain materials. Ions are released and this could eventually lead to implant failure.The oxidation (loss 
of electrons and increase in valence) may result in the release of free ions from the metal surface into 
solution. 
Some studies have measured metal ions levels in the tissue sourronding metal implants, and it has 
been found concentrations from 1µM up to 200µM [16].
2.2.3 Implant loosening
One of the primary reasons for implant failure is the loss of bone implant contact – called aseptic 
loosening and the destruction of bone tissue in the area surrounding the prosthesis (fig 7), what is call 
osteolysis.  
An inadequate initial fixation, mechanical loss of fixation over time, or biological induced loss of fixation 
will lead to an osteolysis around the implant. Wear particles from the implant are the major cause of 
biological induced aseptic loosening. In vitro studies of macrophage cultures indicated that smaller 
polymethylmethacrylate (PMMA) and PE particles (< 20 μm) elicited a inflammatory response, with a 
release of cytoquines. Although particle phagocytosis has been identified as a critical component of 
this biologic  response,  and more over,  new studies had reported that  direct  interactions between 
particle and cell surface are enough to activate osteoclastogenic signaling pathways [17].
Figure 7. Osteolytic lesions in a hip TJR.
Others  mechanisms  run  in  the  same  direction,  as  the  one  studied  in  this  thesis  or  the  metal 
hypersensitivity. The induced osteocyte death near the implant and subsequent bone resorption could 
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be explained due to the effect of the metal with the surrounding tissue. It is know that some metals can 
cause  hypersensitivity  in  contact  with  the  skin,  for  example,  nickel  [18].  However,  it  is  not  clear 
whether  similar  processes take place in  the depth  of  the tissue as well.  Delayed hypersensitivity 
reactions of the type IV (refers to undesirable reactions produced by the normal immune system) have 
been suggested to contribute to the loosening of orthopaedic implants, but the correlation still awaits 
confirmation.  Dermal  hypersensitivity  to  metal  is  common,  affecting  about  10%  to  15%  of  the 
population [19].
In the other hand, is well know that implant alloys in contact with biological systems undergo corrosion, 
leading to the release of metal ions into the periprosthetic tissues and the circulation. [20] Although 
these levels of metal ions can be usually low, but for long exposures may induce a change in the 
hematopoietic microenvironment regulating the turnover of the peri-implant bone.
2.2.4 Inflammation and Hypersensitiviy 
It can be assumed that, to a large degree, metal ions within the circulation will be complexed by serum 
proteins, but is not know if these protein-bound ions (these metal-protein complexes are considered to 
be candidate antigens) or the free ions could explain these stimulatory effects in the lymphocyte cells 
[21],  leading  to  an  inflammatory  effect,  that  in  turns  will  activate  bone  resorption  by  increasing 
osteoclasts (fig 8).
Figure 8 [22]. Inflammatory process due to particle wear or/ and metal ions from the implant. An array 
of cytokines such TNF-α, IL-6, and VEGF are released by monocytes and macrophages in the 
presence of metal ions inducing bone resorption.
These formed organometallic complexes, which can become immunogenic antigens or allergens are 
recognized by antigen-processing cells, which then present the processed antigen to T helper cells. 
The T helper  cells,  in  turn,  send the antigenic  message to either the B cells,  to initiate antibody 
formation, (type I hypersensitivity) or to the cytotoxic T cells to initiate cell-mediated immunity; (type IV 
hypersensitivity,  common with metals). Although the specifics associated with metal-protein binding 
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and the biological  mechanisms by which these complexes become immunogenic remain relatively 
uncharacterized. Metals known as sensitizers are beryllium, nickel, cobalt, and chromium, tantalum, 
titanium and vanadium have been reported. Nickel is the most common metal sensitizer in humans, 
followed by cobalt and chromium. The prevalence of metal sensitivity among the general population is 
approximately  10%  to  15%  (Figure  8),  with  nickel  sensitivity  having  the  highest  prevalence 
(approximately 14%). The amounts of these metals found in medical-grade alloys are shown in Table 
1. 
Table I: Weight Percentages of Metals within the Three Most Common Orthopaedic Alloys
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Figure 9: Averaged percentages of metal sensitivity (for nickel, cobalt, or chromium) among the 
general population and among patients with well and poorly functioning implants, based on a number 
of published reports.       
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3. THESIS AIMS
Since  metal  ions  released  from  the  prosthesis  may  be  an  underestimated  cause  of  prosthesis 
loosening, the present thesis will focus the biologic effects and mechanisms occurring in the presence 
of metal ions. Will be focused the next aspects: How osteoclast are afected by the metal ions, if they 
proliferate or unproliferate, or they increase or decrease their activity, and which array of cytoquines 
are released by osteoclast precursors in the presence of the metals. The answers to these questions 
will  give  clues  about  the  osteoclast  precursors  recruitment  and  activation  in  the  periprosthetic 
enviroment.
Monocytes (osteoclast precursors) will  be treated with metal ions  (Ni2+,  Co2+)  in vitro to mimic the 
situation  of  implant  materials  in  vivo.  Osteoclast  development  from  monocytes  will  be  followed 
biochemically and histologically. In parallel a monocytic cell line (THP-1) will be studied to establish a 
cell line for osteoclastogenesis.
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4.  MATERIALS AND METHODS
4.1 Bone Marrow Cells
4.1.1 Description
Bone marrow is the soft tissue found in the cavity of long bones.
There are two types of bone marrow: red marrow (consisting mainly of myeloid tissue) and yellow 
marrow  (consisting  mainly  of  fat  cells).  The  bone  marrow  contains  three  types  of  stem  cells, 
hematopoietic, mesenchymal and endothelial cells. Mesenchymal stem cells are found arrayed around 
the  central  sinus  in  the  bone  marrow.  They  have  the  capability  to  differentiate  into  osteoblasts, 
chondrocytes, myocytes, and many other types of cells. 
Hematopoietic stem cells are stem cells that give rise to all  the blood cell  types including myeloid 
(monocytes  and  macrophages,  neutrophils,  basophils,  eosinophils,  erythrocytes, 
megakaryocytes/platelets, dendritic cells), and lymphoid lineages (T-cells, B-cells, NK-cells). 
Figure 11.Bone marrow lineage. These pluripotent are capable of producing all these types of  cells 
depending on the signals they receive.
For  this  thesis,  murine  bone  marrow  was  extracted  and  cultured  on  plates.  Monocytes  and 
macrophages from the BMC are treated with RANKL protein to obtain osteoclasts.
4.1.2 Isolation of mouse marrow cells
6-8 week old, male ddy-mice were euthanized in CO2 and bathed in EtOH 70%, the femurs and tibias 
were removed and place in ice-chilled Hank’s (α-MEM, low bic). All muscle tissue was cleaned from 
the bones. To open the marrow cavity, the ends (epiphyses) were cut. Every bone was flushed with 
5ml  of  chilled  Hank’s  solution.  The  cell  suspension  was  collected  in  a  Falcon  50  ml  tube  and 
centrifuged for 5 minutes at 250 x g at 4°C. After centrifugation, the supernatant was removed, and 
cells were resuspended in 30ml α-MEM. For counting the number of cells, the previous solution were 
diluted 1:10 in Turk’s solution (lyses erythrocytes), and a drop were added to the counting chamber. 
Depending on the concentration, the appropriate volume was used to obtain a final cell suspension of 
300’000 cells/ml.
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4.1.3 Culture of bone marrow cells
To investigate the reactions of  o to metal ions, BMC (300’000 cells/ml) cells prepared as described 
above, they were seeded at a density of 60’000 cells in 200µl medium per well in a 48-well plates 
(FALCON, Fisher Scientific, Wohlen,  CH). The medium composition was α-MEM with 10%FBS, 1% 
Pen/Strep and recombinant human CSF-1 (Cetus Corporation, Anaheim, CA, USA) to a concentration 
of  30ng/ml.  Desired  concentrations  of  recombinant  human soluble  RANKL (sRANKL;  PeproTech, 
London,  GB)  and  metal  salts,  NiCl2 and  CoSO4, were  added  at  different  time  points  and 
concentrations depending on the experiment.
Plates were incubated at 37°C, 5% CO2. Cells were cultivated under know conditions for five to nine 
days. Each 3 days medium was changed, removing old medium with no adherent cells, and adding 
new medium with the desired concentrations of metal ions and cytoquines.
BMC cultures for XTT assay were seed in 100 µl (30.000cells) per well in a 96-well plates (FALCON, 
Fisher Scientific, Wohlen, CH), with same media and conditions mentioned above.
4.1.4  Differentiation of BMC to osteoclast, Determining RANKL dose response
BMC cells were cultured in 48-well plates with CSF-1 to a concentration of 30ng/ml and 5 groups with 
different RANKL concentrations (0, 2.5, 5, 10, 20 ng/ml). 6 repetitions per group, incubated at 37°C, 
5% CO2  for 3 to 5 days. Trap staining assay was done at day 3, 4 and 5 to determine the number of 
multinucleated osteoclasts formed with the different conditions.
4.1.5  Cobalt and Nickel effects on Osteoclast formation
BMC cells were cultured in 48-well plates with CSF-1 to a concentration of 30ng/ml, 5 groups with 
different RANKL concentrations (0, 2.5, 5, 10, 20 ng/ml) and 3 concentrations 0µM (control group),10 
µM and 100 µM for the desired ion (Nickel or Cobalt) . 6 repetitions per group. Trap staining assay 
was done at day 3, 4 and 5  to determine the number of multinucleated osteoclasts formed with the 
different conditions.
4.1.6  Cobalt  and Nickel effects on cell proliferation
BMC cells were cultured with CSF-1 to a concentration of 30ng/ml, and 5 groups with different RANKL 
concentrations (0, 2.5, 5, 10, 20 ng/ml) and 3 concentrations 0µM (control group),10 µM and 100 µM 
for the desired ion (Nickel or Cobalt). 6 repetitions per group in 96 well plates.  Cell Viability Assay 
(XTT) was done to assess how metal ions can affect cell viability.
4.1.7 Effects on cell proliferation and Osteoclast formation, up to 9 days 
The purpose of the current experiment was to assess longer-term effects of the ions on monocytes 
(osteoclast precursors). BMC cells were cultured with CSF-1 to a concentration of 30ng/ml, and 5 
concentrations 1, 3, 10, 30, 100 µM for Nickel ion and 5 more groups for Cobalt ion. 6 repetitions per 
group. 96 well plates were used for posterior XTT assay and 48 well plates were used for Trap 
staining assay. 
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For the 96 well plates, cellular proliferation was measured at 9 timepoints (Day3 to Day9). 
For the 48 well plates, at  days 4, 6, 8 and 9, RANKL was added in two concentrations (5 and 20 
ng/ml) to induce differentiation to osteoclasts, and after 4 days treatment with RANKL. Trap staining 
assay was done.
4.2  Peripheral Blood Mononuclear Cells 
4.2.1  Description
Peripheral  Blood  Mononuclear  Cell  (PBMC)  is  a  blood  cell  having  a  round  nucleus,  such  as  a 
lymphocyte or a monocyte. They are a critical component in the immune system to fight infection and 
adapt to intruders. The lymphocyte population consists of T cells, B cells and NK cells.
These  cells  are  often  extracted  from whole  blood  using  Ficoll,  a  hydrophilic  polysaccharide  that 
separates layers of blood (fig 12), with monocytes and lymphocytes forming a buffy coat under a layer 
of plasma. This buffy coat contains the PBMCs.
Figure 12. Tube containing blood separated in 3 layers after centrifugation.
The buffy coat is the fraction of an anticoagulated blood sample after density gradient centrifugation 
that contains most of the white blood cells and platelets. After centrifugation, 3 layers are formed, the 
plasma (clear fluid), the red blood cells, and a thin layer in between (less than 1% of the total volume 
of the blood sample), call the buffy coat, containing most of the white blood cells and platelets. 
4.2.2 Isolation of Peripheral Blood Mononuclear Cell
Human PBMC were isolated from buffy coats obtained from healthy donors (Swiss Red Cross Blood 
Services Bern AG, Berne, CH), by Ficoll/Hypaque (Oxoid, Basle, CH) gradient centrifugation. Briefly, 
the buffy coats were diluted 1:8 with RPMI1640 medium (SIGMA, Buchs, CH), placed on top of Biocoll 
separation solution (ratio 3:2),  and centrifuged for 20 min at  1200 g at RT. The upper layer  was 
discarded,  while  the interphase,  containing the PBMC, was washed twice  with  phosphatebuffered 
saline (PBS) and resuspended in RPMI1640/5% FBS (Inotech AG, Dottikon, CH), containing 1.5% 
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Hepes buffer (SIGMA, Buchs, CH) and 1% penicillin/streptomycin (GIBCO BRL, Life Technologies, 
Basle, CH). Subsequently, the monocytes were separated from the cells of the lymphoid lineages by 
their capacity to adhere to plastic surfaces.
4.2.3 Culture of Peripheral Blood Mononuclear Cells
4 x 106 cells PBMC per well cells were seeded in 1ml medium in a 24 well plate (FALCON, Fisher 
Scientific, Wohlen, CH). After 3 h, the non-adherent cells were removed and new medium was added. 
Medium was composed of RPMI-1640 containing 5% FBS (heat inactivated), 1.5% HEPES and 1% 
penicillin/streptomycin (all purchased from GIBCO Invitrogen AG, Basle, CH). Plates were incubated 
at 37°C, 5% CO2.
4.2.4  Comparison THP-1 cells versus Human PBMC stimulated with metal ions
To study which genes are encoded, and which cytoquines are released in response to metal ions, 
THP-1 cells were cultured at 1.5 x 106 THP-1 cells in 1ml THP-1 medium per well,  with 5 groups 
(control,  Ni2+ 10µM,  Ni2+ 100µM,  Co2+10µM and  Co2+  100µM).  As  a  positive  control  PBMC were 
cultured under the same conditions and concentrations. 
At 7 timepoints ( 0 hours – control groups only, 2, 4, 8, 16, 24, 48 hours) samples were taken for RT-
PCR and ELISA assays following the next instructions; For PBMCs; supernatants were collected and 
centrifuged at 1000 rpm / 4ºC for 10 min; for each sample, 900µl of the supernatant was stored for 
ELISA assay. Adherent cells from the plates were washed  with PBS and lysed for preparing the RNA.
For THP-1, cell suspensions were collected, centrifuged at 1000 rpm / 4ºC for 10 min; for each sample 
900µl of the supernatant was stored for ELISA assay. Cells remaining in the culture plate were lysed 
and  transferred  to  the  cell  pellet  derived  from  the  centrifugation  step  before  to  lyse  previously 
suspended cells, for the preparation of  RNA.
4.3 THP-1: Human acute monocytic leukemia cell line
4.3.1  Description
Human acute  monocytic  leukaemia  cell  line  (THP-1)  where  derived  from the  peripheral  blood  of 
human male with acute monocytic leukaemia, the first THP-1 cell line was cultured from a 1 year old 
boy with monocytic leukemia isolated in the 1980 by Tsuchiya [23].  They were chosen based on their 
extensive prior use as a model for peripheral blood monocytes [24]. THP-1 cells easily differentiate 
into macrophage. They express Fc and C3b receptors and a lack of cytoplasmic immunoglobulins. By 
the addition of Vitamin D3 they adhere to cell culture flasks.
Clearly, the use of the THP-1 cell line is a compromise over PBMC, because THP-1 cells divide 
continuously and PBMC do not. However, experience and previous reports have established the 
difficulties in maintaining a reproducible culture of PBMC for 4 weeks because of the transitions that 
occur in cellular attachment, the need for critical growth factors, and the slow degradation of the 
cultures [25]. The THP-1 model at least provides a monocytic cell that retains many of the functional 
properties of PBMC [26].  Today, there are non human cell culture systems for osteoclast studies, like 
the murine RAW 264.7 macrophage cell line, that can differentiate into osteoclasts when stimulated 
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with RANKL alone. Finding a human cell line that supports differentiation in cell culture to osteoclasts 
is still in research.
4.3.2  Culture of THP-1 cells
For the culture of THP-1 cells the suggested medium composition was chosen: RPMI 1640 (GIBCO 
724000-021)  containing  10% FCS Hia  (PAA Lab.A15-043   /  Lot:  A01127-314),  1% Na-Pyruvate 
(GIBCO 11360-039), 1% MEM NEAA (GIBCO 11140-035), 1% MEM Vitamin (GIBCO 11120-037), 
1% Penecillin / streptomycin (GIBCO 15140-122), 0.1% 2-Mercaptoethanol (SIGMA M-7522). Cells 
were  cultured  in  flasks  (FALCON,  Fisher  Scientific,  Wohlen,  CH)  with  an  initial  concentration  of 
400000 cells/ml in a 15 ml total volume of medium, at 37C, 5% CO2. Passages were done each 3 
days, where medium with cells in suspension were collected to a 50ml Falcon tube, and centrifugated 
at 1000rpm/4ºC for 5 min. Supernatant was removed, thereafter cells were resuspended in 1ml THP-1 
medium, and fill up to 30ml. Cells were counted, and a new flask was prepared with  400000 cells/ml 
in a 15 ml THP-1 medium.
4.3.3  CSF-1 effect on THP-1
To study the effect of CSF-1 (Cetus Corporation, Anaheim, CA, USA) on the proliferation of THP-1 
cells, 3 concentrations (2500, 5000, 10000 cells/well) of THP-1 were cultured in 96 wells plates 
(FALCON, Fisher Scientific, Wohlen, CH) with different CSF-1 concentrations (0, 10, 20, 40, 100 
ng/ml). Six repetitions per concentration. XTT assay was done at day 1, 2, 3 and 4.
4.3.4  THP-1 Differentiation
Differentiation of  the human monocytic  cell  line THP-1 into macrophage-like cells was induced by 
adding to the THP-1 medium 30ng/ml CSF-1, 0.1% 1.25(OH)Vitamin D3 (10-8 M; Roche, Basle, CH) 
and 0.03% Dexamethasone. Six repetitions per concentration. Change of media was done each 3 
days. After one week with the previous conditions, RANKL (0, 5, 10, 25, 50 ng/ml) was added to 
induce osteoclast  differentiation,  and the treatment was stopped after 4 days,  when Trap staining 
assay was realized.
4.4  Trap staining
A TRAP staining kit  (Sigma-Aldrich Chemie)  was used for this thesis.It  relies on the unspecific 
inhibition of phosphatases other than TRAP by large amounts of tartrate and highly acidic milieu. 
Naphtol-Anilid-Acid-Biphosphate is used as a substrate for dephosphorylation, leading to a product 
that is bound to Fast Garnet GBC leading to an insoluble, purple precipitate.
Trap assay is done following the next procedure; Once wells are washed with 1XPBS to remove 
non adherent cells, a 4% paraformaldehyde solution in 1xPBS is used for 10 min to fix the cells 
remaining in the wells. Thereafter, wells are washed with distilled water (3x). For staining, Naphtol-
Anilid-Acid-Biphosphate (Sigma Diagnostics, Buchs, CH) is mixed with Fast Garnet GBC (Sigma 
Diagnostics, Buchs, CH) according to the protocol, and added to the wells for 5 min. Finally wells 
are washed (3x) with distilled water.
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Figure 15. Example of Osteoclast after Trap+ Staining.20x Bright Field.
4.5  Cell Viability Assay
XTT is a colorimetric method based on the tetrazolium salt. Metabolic active cells to reduce the 
tetrazolium salt to orange colored compounds of formazan.The dye formed is water soluble and the 
dye intensity can be read at a given wavelength with a spectrophotometer. The intensity of the dye 
is proportional to the number of metabolic active cells.The greater the number of active cells in the 
well, the greater the activity of mitochondria enzymes, and the higher the concentration of the dye 
formed.
Assay was done following the protocol given with the XTT kit from Roche Applied Science; XTT 
labeling mixture was prepared by mixing XTT labeling (50µL/well) and electron coupling reagent 
(1µL/well) at 37ºC. The XTT labeling mixture was added to the wells (50µL/well) and incubated for 
2  hours  at  37ºC.  Absorbance  was  read  after  the  incubation  period,  using  a  ELISA  reader 
(microplate spectrophotometer) at 450-500nm with a reference wavelength at 650nm.
4.6 Enzyme-Linked ImmunoSorbent Assay (ELISA)
Is a biochemical  technique to detect the presence of an antibody or an antigen in a sample. In 
ELISA an  unknown  amount  of  antigen  is  affixed  to  a  surface,  and  then  a  specific  antibody  is 
washed over the surface so that it can bind to the antigen. This antibody is linked to an enzyme, 
and in  the final  step a substance is  added that  the enzyme show fluorescence.  To assess the 
amount of antigen in the sample, fluorescence is read. The more fluorescence the more antigen.
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Figure 16. ELISA schematic assay: 1-Bind, 2-wash, 3-label, 4-read.
4.6.1  Determination of cytokine levels by ELISA
ELISA’s were done according protocol from ELISA kit from BD Biosciences. 
Levels  of  TNF,  IL8  and  VEGF  in  conditioned  media  were  determined  by  enzyme  linked 
immunosorbent assays (OptEIA Human Cytokine Sets (TNF and IL8), Pharmingen, BD Bioscience, 
Allschwil, CH; Duoset ELISA Development System (VEGF), R&D Systems Europe Ltd. Abingdon, 
UK) as recommended by the manufacturer.
Recombinant  proteins  were  used  to  generate  the  standard  curves.  The  product  of  the  HRP-
catalyzed  reaction was  determined spectrophotometrically  (Benchmark  Microplate  Reader,  BIO-
RAD; Infinite M200, Tecan Switzerland AG, Männedorf, CH) at 450 nm and background correction 
was performed at 570 nm. 
4.7 Real-time polymerase chain reaction (RT-PCR)
Real-time polymerase chain reaction is combined with reverse transcription polymerase chain reaction 
to  quantify  with  accuracy  messenger  RNA  (mRNA)  from  a  sample.  It  permits  to  quantify  the 
abundance of a gene expression at a particular time in a particular cell. RT-PCR amplifies a small 
quantity of the desired RNA with the reverse transcription of the RNA to cDNA, which is subsequently 
amplified.
4.7.1  Determination of mRNAs levels by RT-PCR
To determine the levels of mRNAs encoding cytokines synthesized by monocytes treated with metal 
ions, total RNA was isolated using the RNeasy Mini Kit from Qiagen (Basle,  CH), according to the 
recommendations  of  the  manufacturer.  For  amplification  in  an  ABI  PRISM 7700 system (Applied 
Biosystems,  Rotkreuz,  CH),  the following Assays-on-Demand (Applied Biosystems,  Rotkreuz,  CH) 
were used: TNF-α, IL-8; and VEGF. The CT values were normalized against 18S rRNA. The reactions 
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were  performed  using  TaqMan  Universal  PCR  Master  Mix  (Applied  Biosystems,  Rotkreuz,  CH), 
Assay-on-Demand mixture diluted 1:20, and 1 ng (0.01 ng for 18S rRNA) cDNA. The reactions were 
preincubated for 2 min at 50°C, followed by 10 min at 95°C. Thereafter, 45 cycles of 15 s at 95°C and 
1 min at 60°C each were performed. The reactions were analyzed using the ABI PRISM sequence 
detection application software SDS V1.9.1.
5. RESULTS
5.1Establishing an alternative osteoclast culture
5.1.1 Determining CSF-1 dose response on THP-1 cells
Thp-1 cells were treated with CSF-1 to investigate which concentration of this cytoquine was inducing 
more growing in the cell culture.
Figure 21.Relative Nº of viable cells ; mean  + standard deviation; n=6;
The relative number of cells was measured by XTT assay, results are showed in the figure 21. The 
number of cells was not affected by the addition of CSF-1 to the culture medium in any of the 
concentrations used over the experiment. 
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5.1.2 Differentiation of THP-1 cells 
To asses THP-1 differentation to macrophages, vitamin D3 and dexamethasone was added to the 
medium. After one week with this conditions culture, the cells were adhering to the dish bottom 
(fig.22), and they were presenting changes in cell morphology. At this point, RANKL was added for 4 
days to asses osteoclast differentation, but Trap staining assay showed any trap activity, indicating a 
non evidence for osteoclast formation. 
Figure 22. Bright Field x 20; Cells are attached to the bottom of the well and present morphological  
changes typical from macrophages.
5.1.3 Gene Expression
To investigate the response of THP-1 and monocytes from peripheral blood to an exposure to metal 
ions, the cells were treated with 10µM, 100µM Ni2+, and 10µM, 100µM Co2+, from 2h up to 48 h, and 
levels of IL-6, TNF, and VEGF were determined by RT-PCR (fig 23). 
Figure 23. Gene expression for IL-6, TNF-alpha  and VEGF (Relative mRNA levels for the different 
concentrations of metal ions). Upper graphics for PBMC and lower for THP-1.
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It  was found in common for both types of cells,  that  the higher expressions of   the 3 cytoquines 
studied, were released in the first 4 hours, but with different patterns, then for PBMC's, the higher the 
concentration of metal ion, the less cytoquines released, and for THP-1 the other way around, having 
in both cases more effect the Cobalt ion. For the next timepoints (8 hours till the 48h), the release of 
cytoquines is highly decreased, except for VEGF, being 50% reduced. 
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5.1.4 Cytokine secretion 
 To assess the kinetics of the release, supernatants were collected after 2, 4, 8, 16, 24 and 48 h and 
the levels of cytokines were determined by ELISA (fig 24). 
Stimulation of PBMC with metal Ions Stimulation of THP-1 with metal Ions
Figure 24. Results ELISA for TNF-alpha,IL-6 and VEGF; PBMC left column and THP-1 right column.
TNF was not found neither in the THP-1 and PBMC supernatants.
IL-6 was increased over the time, with higher values for 100µM Nickel. IL-6 was negative for THP-1. 
For VEGF only appeared after 16h for the PBMC, being much higher for the 100µM Nickel. A different 
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pattern  is  observed  for  THP-1,  where  VEGF protein  was  secreted  in  the  same amounts  for  the 
different conditions, increasing over the time. 
5.2 Ni and Co effects on osteoclast formation
5.2.1 Differentiation of BMC to osteoclast, Determining RANKL dose response
BMC where treated with RANKL concentrations 0, 2.5, 5, 10, 20 ng/ml to asses a correlation between 
levels of RANKL and number of osteoclasts. It was probe that RANKL it is an essential 
osteoclastogenic factor, and the major number of osteoclast was assessed with the concentration of 
20ng/ml, and the higher levels where obtained at day 5 (Fig 25).
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Figure 25. Nº osteoclast; mean +/- standard deviation; n=6;
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5.2.2  Metal ion effects on Osteoclast formation
Nickel  and  cobalt  salts  were  added  to  osteoclast  cultures  to  assess  their  influence  on  BMC 
differentiation to osteoclasts up to 6 days. Results from the Trap activity assays are showed in the 
following graphics (fig 26-27).
Ni2+ and Co2+ ions did not stimulated differentiation up to day 5. However at day 6, the pattern was 
different for Nickel,  where the number of osteoclasts where similar to the number obtained in the 
control group. 
Figure 26. Nickel treatment; Nº osteoclast; mean +/- standard deviation; n=6;
Figure 27. Cobalt treatment; Nº osteoclast; mean +/- standard deviation; n=6;
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5.2.3 Metal ion effects on cell proliferation
The influence of metal ions in the cell proliferation was tested and analyzed through the colorimetric 
assay XTT (fig 28-29) starting at day 3 up to 6 days. Both metal ions presented a decrease effect on 
cell proliferation for 100µM concentration. However, for the 10µM concentration, the pattern was 
different for the 2 metals. It appeared that nickel was inducing a small increase on cell proliferation.
A considerable difference between RANKL stimulated and non  stimulated cells is observed, this may 
be explained because cells are pushed  to differentiate to osteoclast  in  the presence of  RANKL, 
loosening their capacity to proliferate.
Figure 28. Nickel treatment; Nº osteoclast; mean +/- standard deviation; n=6;
Figure 29. Cobalt treatment; Relative Nº of viable cells; mean + standard deviation; n=6;
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5.3 Effects on cell proliferation and Osteoclast formation, up to 9 days 
Figure 30. Relative Nº of viable cells; mean + standard deviation; n=6; A: nickel ions ; B: cobalt ions.
The changes seen in the previous experiments for longer expositions (day 6) to metal ions pushed to 
extend the duration of the experiments up to 9 days. At this time, the pattern of the effect was different 
for each metal ion. 
For nickel, as graphic is showing (fig 30-A), 100µM Ni2+ was delaying the cell proliferation almost 3 
days, but after this period, the number of viable cells were reaching the same maximum as control 
cells. This appreciation was particular strong for 100µM concentration, but not appreciable for the 
other concentrations, that are following same pattern as control  cells. Two tendency lines have been 
added to the graphic for a better visualizing , yellow color for control and low concentrations, and the 
brown for 100µM.
For cobalt ion (fig 30-B), the highest concentration is inhibiting cell proliferation. And for low 
concentrations, it was observed a similar pattern to 100µM Ni2+ , delaying the proliferation. 3 tendency 
lines were added to the graphic, gray for control, clear blue for 10µM Co2+ , and dark blue for 100µM 
Co2+.
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To investigate the capacity of the cells to differentiate to osteoclasts after the treatment with 
metal ions, RANKL was added to conditioned media at 4 stages of the culture, day 4, 6, 8 and 
day 9. Culture plates were incubated 4 days more with new media conditions, after that, 
cultures were stopped and Trap staining assays were done, and subsequent microscopic 
photographs were taken (fig 30).
Figure 30. Microscopic images (bright field x5)  of TRAP stained cells with different duration times of 
treatment with nickel ions.
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For the 3 first conditioned media, there was not a significant difference, indicating no effect of the 
metal ion for the BMC cultures.
For the highest concentration, 100µM Ni2+,  there was a considerable effect,  moreover at day 4, 
where plenty of trap activity was detected, indicating more osteoclast differentiation.
6  Discussion
Within the present thesis, it has been confirmed and extended previous studies describing how metal 
ions released from metallic biomaterials may have adverse biological and functional effects. 
In this thesis it has been showed the maturation of monocytes to macrophages from THP-1 cells by 
the  induction  of  CSF-1,  Vitamin  D3  and  Dexamethasone.  However not  osteoclast  lineage 
differentiation  had  been  observed  by  the  addition  of  RANKL.  This  could  be  explained  because 
sometimes the differentiation ability can be lost during numerous passages of subcultivations in cell 
lines, and may be the case for our THP-1 cells,  or another explanation could be that THP-1 cells 
needs additional accessory factors to differentiate to osteoclasts.
The cell  culture  model  used in  the present  work  was selected because BMC can follow multiple 
differentiation pathways, one of them to osteoclast lineage. The metal ions treatment (mimicking the 
corrosion ions derived form implants)   had permit  to investigate  the effects on the formation and 
function of osteoclastic cells, trying to mimic the events that are occurring in the periprosthetic region.
The high concentration (100µM) chosen for the cobalt  ion resulted lethal,  drastically  reducing the 
number of osteoclasts. However, for the nickel ion, it was found that is somehow inducing a delay in 
the osteoclast formation; similar levels of osteoclast were reached an average of 4 days later that with 
the non-treated cells.  These findings suggest  that nickel is not inhibiting osteoclast formation, and 
could permit an increase on cell proliferation during this delay, incrementing the pool of precursors 
cells, leading at the end in a major number of osteoclasts in the periprosthetic tissue.
It has been characterized in previous studies that monocytes release numerous cytokines in response 
to an exposure to metal ions. This response depends on the metals the cells are treated with, since 
specific transcripts were found to be upregulated either by Co2+ or Ni2+ [27]. In the present research, 
the results from cytoquines and mRNA expression were not conclusive, and will need revision.
It is unclear whether metal ions inhibit bone resorption (effects on osteoclast progenitors) or promote 
resorption (immunogenic reactions that permits recruitment of osteoclast precursors) that leads at the 
end to the implant failure or vice versa. It is likely that some combination of these phenomena occurs, 
which in turn act to potenciate the loosening cascade. It has to be taken in account that in any in vitro 
model such as the one used in the current study, the relevance of the results to clinical practice can 
differ. Mechanisms by which in vivo implant failure occurs have not been well characterized, however 
present study had been an approach, giving some clues about the signaling cascades and cellular 
responses to the metals ions.
Future investigations could lead to implants with better osteointegration and long term biocompatibility 
and  durability.  Therefore,  improvements  in  implants  could  regard  strategies  to  act  directly  at  the 
cellular  components  that  contribute  to  implant  failure.  Some  approaches  could  be  to  regulate 
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osteoclast precursor cells, or target precursors that are stimulated by the wear particles or the metal 
ions, or regulate the activation mechanism of multinucleated osteoclasts.
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